- Home
- IVR vs AUTL Comparison
IVR vs AUTL Comparison
Compare IVR & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVR
- AUTL
- Stock Information
- Founded
- IVR 2008
- AUTL 2014
- Country
- IVR United States
- AUTL United Kingdom
- Employees
- IVR N/A
- AUTL N/A
- Industry
- IVR Real Estate Investment Trusts
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IVR Real Estate
- AUTL Health Care
- Exchange
- IVR Nasdaq
- AUTL Nasdaq
- Market Cap
- IVR 515.0M
- AUTL 590.8M
- IPO Year
- IVR 2009
- AUTL 2018
- Fundamental
- Price
- IVR $8.18
- AUTL $2.19
- Analyst Decision
- IVR Buy
- AUTL Strong Buy
- Analyst Count
- IVR 2
- AUTL 3
- Target Price
- IVR N/A
- AUTL $10.20
- AVG Volume (30 Days)
- IVR 1.8M
- AUTL 1.4M
- Earning Date
- IVR 02-20-2025
- AUTL 03-13-2025
- Dividend Yield
- IVR 19.45%
- AUTL N/A
- EPS Growth
- IVR N/A
- AUTL N/A
- EPS
- IVR 1.23
- AUTL N/A
- Revenue
- IVR $102,893,000.00
- AUTL $10,091,000.00
- Revenue This Year
- IVR N/A
- AUTL $851.83
- Revenue Next Year
- IVR $8.53
- AUTL $264.18
- P/E Ratio
- IVR $6.68
- AUTL N/A
- Revenue Growth
- IVR 654.96
- AUTL 82.71
- 52 Week Low
- IVR $7.48
- AUTL $2.07
- 52 Week High
- IVR $9.97
- AUTL $7.37
- Technical
- Relative Strength Index (RSI)
- IVR 51.78
- AUTL 37.25
- Support Level
- IVR $7.48
- AUTL $2.18
- Resistance Level
- IVR $8.29
- AUTL $2.38
- Average True Range (ATR)
- IVR 0.19
- AUTL 0.16
- MACD
- IVR 0.02
- AUTL 0.01
- Stochastic Oscillator
- IVR 85.80
- AUTL 3.17
About IVR INVESCO MORTGAGE CAPITAL INC
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.